1-2 of 2
Emel Gurkan, MD
Close
Sort by
Journal Articles

Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Anil Tombak, MD, Funda Pepedil Tanrikulu, Salih Sertac Durusoy, Emel Gurkan, MD, Emin Kaya, MD, Elif G Umit, MD, Irfan Yavasoglu, MD, Özgür Mehtap, MD, Burak Deveci, Mehmet Ali Ozcan, MD, Hatice Terzi, Mufide Okay, MD, Nilgun Sayinalp, MDPROF., Mehmet Yilmaz, MD, Vahap Okan, Alperen Kizikli, Omer Ozcan, Güven Çetin, Sinan Demircioglu, Ismet Aydogdu, MD, Guray Saydam, MD, Eren arslan Davulcu, Gul Ilhan, Mehmet Ali Ucar, Gulsum Ozet, MD, Seval Akpinar, Burhan Turgut, MD, Ilhami Berber, Erdal Kurtoglu, Mehmet Sönmez, MD, Derya Selim Batur, Rahsan Yildirim, Vildan Ozkocaman, MD, Ahmet Kursat Gunes, Birsen Sahip, Sehmus Ertop, Meltem Akay, Abdulkadir Basturk, Mehmet Hilmi Dogu, Aydan Akdeniz, Ali Unal, MD, Ahmet Seyhanli, Burhan Ferhanoglu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5476.
https://doi.org/10.1182/blood-2019-126402
Published: 2019
Journal Articles

"Prophylactic" Platelet (PLT) Transfusions in the Setting of Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): Similar Clinical Efficacy of Single Donor (SDP) and Random Donor Pooled (RDP) Platelet Products.

Poliana A. Patah, MD, Emel Gurkan, MD, Rima Saliba, PhD, Marcos de Lima, MD, Gabriela Rondon, MD, Carlos A. Ramos, MD, Daniel Couriel, MD, Jonas A. de Souza, MD, Richard Champlin, MD, Benjamin Lichtiger, MD
Journal: Blood
Blood (2006) 108 (11): 597.
https://doi.org/10.1182/blood.V108.11.597.597
Published: 2006